BiDil as an Example of Racialized Medicine

BiDil, a drug that is marketed as treating heart failure in Black people, was initially praised as the first "race-specific" medicine to be approved by the US Food and Drug Administration (FDA). It was especially praised for focusing on Black people, who have been historically overlooked in medicine. However, a closer reading of the BiDil case shows how it reinforced false and harmful assumptions about race in humans.